bulk drugs

Morepen Labs reports 24 % rise in its net sales and 34% rise in net profit in first half of FY 2019-20 led by a significant jump in its Bulk Drugs and Home Diagnostics businesses

New Delhi, November 28, 2019: Morepen Laboratories Ltd. has reported a Net sales Revenue (Standalone) of Rs. 383.30 crore in…

4 years ago

Morepen Labs begins FY 2018-19 with a Sound Performance in the First Quarter

Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420